Rankings
▼
Calendar
CRDF Q4 2020 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena
CRDF
Cardiff Oncology, Inc.
$133M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$119,255
+28.8% YoY
Gross Profit
$119,255
100.0% margin
Operating Income
-$6M
-5447.9% margin
Net Income
-$7M
-5531.9% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
-12.3%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$943,835
Balance Sheet
Total Assets
$135M
Total Liabilities
$7M
Stockholders' Equity
$128M
Cash & Equivalents
$131M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$119,255
$92,577
+28.8%
Gross Profit
$119,255
$92,577
+28.8%
Operating Income
-$6M
-$4M
-51.5%
Net Income
-$7M
-$4M
-55.5%
← FY 2020
All Quarters
Q1 2021 →